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Abstract
This study investigated the effect of enteral administration of obestatin on the development
of small intestine, as well as oxidative stress markers and trancriptomic profile of gastroin-
testinal genes. Suckling rats were assigned to 3 groups treated with: C-saline solution; OL-
obestatin (125 nmol/kg BW); OH-obestatin (250 nmol/kg BW) administered twice daily, from
the 14th to the 21st day of life. Enteral administration of obestatin in both studied doses had
no effect neither on the body weight of animals nor the BMI calculated in the day of euthana-
sia. Compared to the control group (C), treatment with obestatin resulted in significant
changes in the histometry of the small intestinal wall as well as intestinal epithelial cell
remodeling. The observed changes and their possible implications for intestinal develop-
ment were dependent on the dosage of peptide. The enteral administration of high dose
(OH) of obestatin significantly decreased its expression in the stomach and increased mark-
ers of oxidative stress. The gene profile revealed MAPK3 (mitogen-activated protein kinase-
3) as the key regulator gene for obestatin action in the gastrointestinal track. In conclusion,
we have showed that enteral administration of obestatin influences the gut mucosa remodel-
ing. It is also suggested that the administration of high dose (OH) has inhibitory effect on the
intestinal maturation of suckling rats.
Introduction
Obestatin, a 23-amino acid peptide, was originally purified from the rat stomach as a ghrelin-
accompanying peptide, created during the posttranslational modification of polypeptide
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precursor of ghrelin (preproghrelin) [1]. Currently, G protein-coupled receptor 39 [1] and glu-
cagon-like peptide 1 receptor [2] are debatable targets of obestatin. In the study by [1] it was
reported that obestatin shows opposite biological effects to ghrelin and inhibits food intake,
body weight gain, gastric emptying and jejunal contractility. However, the last decade investi-
gations on the physiological role of obestatin demonstrate that obestatin is an independent
peptide, participating in many physiological processes in the organism including the develop-
ment of the gastrointestinal tract in the early postnatal period. Previous studies of our team
have shown that obestatin influences small intestinal contractility in rats [3,4]. We found that
obestatin effect is dependent on the age of animals, segment of jejunum and route of peptide
administration (in vitro studies with obestatin in the intestinal luminal environment vs. enteral
administration to suckling animals). Moreover, the presence of obestatin has been reported in
colostrum and milk [5–7], which firmly proves the significance of obestatin (both endogenous
and exogenous) in the regulation of gastrointestinal function in the early postnatal period. It is
also worth mentioning the study, in which the expression of obestatin immunoreactive (IR)
cells in the both stomach mucosa and myenteric plexus of neonatal rats starting from the 1st
day after birth was observed. It was shown that obestatin IR cells in the stomach mucosa reach
the same number as in adults by 6 weeks after birth, whereas ghrelin-IR cells were not
observed on the 1st day of life. Although their number increased within first week and
remained at this plateau until the month of life, the expression of ghrelin-IR cells were still
lower than those of the obestatin-IR cells [8]. The results show that in the stomach mucosa,
obestatin-IR cells are identified mainly in the fundus and, to some extent, also in the corpus
and antrum. Therefore, the aims of the study were to understand how obestatin administrated
enterally effects on the structural and functional development of intestines in suckling ratsand
at the same time to assess (via the indication of the activity of glycosylases—markers of oxida-
tive stress) the potential side effect of this supplementation on the small intestine samples.
Material and methods
All the experimental procedures involving animals were conducted in compliance with the
European Union regulations concerning the protection of experimental animals (EC Directive
86/609/EEC with amendments). The study protocol was approved by the 3rd Local Ethics
Committee in Warsaw, according to the Polish Law for the Care and Use of Animals (Resolu-
tion no 50/2012).
Obestatin
Rat obestatin was synthesized at the Yanaihara Institute using a solid phase method with an
Fmoc-strategy and an automated peptide synthesizer (Applied Biosystem 9030 Pioneer, Foster,
CA, USA). Analytical HPLC and MALDI-TOF MS confirmed the homology of the product.
The hormone was kept in powder form at -20˚C and then dissolved in saline solution (0.9%
NaCl) to the final concentration, just before use.
Animals
At the start of the experiment 12 male and 12 female Wistar Han rats (13 weeks old) were
used. Animals were purchased from the Center of Experimental Medicine at the Medical Uni-
versity of Bialystok. After two weeks of acclimatization the rats were mated. After mating,
females were separated from males and they were allowed free access to commercial rat breed-
ing chow (5% fat; 3.1 kcal/g, Wytwornia Pasz Morawski, Poland) and tap water in a humidity-
and temperature-controlled room on a 12-h:12-h light:dark cycle. Twenty-four hours after
delivery litters were standardized to 10 pups. On the 14th day of life the rat pups (n = 120)
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form 12 litters were randomly assigned to one of 3 treatment groups (4 litters for each treat-
ment): C- control animals- treated with saline solution; OL- pups treated with a lower dose of
obestatin at 125 nmol/kg BW; OH-pups treated with a high dose of obestatin at a 250 nmol/kg
BW. Both pharmacological doses of obestatin were constructed based on the previous in vitro
studies on intestinal contractility in rats [3,4]. Prior to euthanasia, all pups were housed with
their mothers and breast-fed ad libitum. Saline solution or obestatin were administered enter-
ally via oral gavage twice a day staring from the 14th day of life until the 21st day of life. On the
21st day of life (30 min after the morning NaCl/obestatin treatment) 4 randomly selected rat
pups from each litter (n = 16 for each treatment) were euthanized by CO2, while the rest were
taken for another experiment.
Duodenum, middle jejunum and ileum were transected and samples of each section were
collected and immediately fixed in a 10% neutral formalin solution or deep frozen and stored
in -80 ˚C. Blood for radioimmunoassays was collected via cardiac puncture, withdrawn on
EDTA and aprotinin (0.6 TIU/mL of blood) than immediately centrifuged (1.600 x g, 15 min,
4 ˚C), distributed to Eppendorf tubes, deep frozen and stored until analysis (-80 ˚C).
Microarray analysis
Tissue samples were homogenized using TissueLyser LT (Qiagen, USA). Total RNA from
homogenized tissue samples was isolated using Rneasy Mini Kit (Qiagen, USA). DNAse I
digestion as a step of isolation protocol was added to remove contamination of sample with
DNA. This was performed using RNase-Free DNase Set (Qiagen, USA). NanoDrop (Nano-
Drop Technologies, USA) was used for quantification of RNA. Final RNA quality and integrity
were analysed using Agilent 2100 Bioanalyzer (USA) with the use of RNA 6000 Nano Kit (Agi-
lent, Germany). Only RNA samples with Relative Integrity Number (RIN) number�7.8 were
considered as optimal and included in further analysis.
Gene expression profile was evaluated using Agilent platform, including Agilent-028279
SurePrint G3 Rat GE 8x60K Microarray (Agilent Technologies, USA) and Agilent Technolo-
gies Reagent Set. All procedures were run according to the manufacturer’s protocols. Internal
control, added to the samples, came from RNA Spike In Kit (Agilent Technologies, USA),
whereas amplification and labelling of target DNA in order to obtain complementary RNA
(cRNA) were performed using Low Input Quick Amp Labeling Kit. Fragmentation and
hybridization of cRNA were performed using Gene Expression Hybridization Kit and slides
after hybridization were washed using Gene Expression Wash Buffer Kit. Agilent DNA Micro-
array Scanner G2505C was used for acquisition and analysis of hybridization intensities.
For the microarray experiment tissues from 4 randomly selected rats per one experimental
group were sampled, representing both stomach and middle part of intestine; control group
(C) or High Obestatin (OH) groups. For the purposes of microarray experiment we were
using common reference design, in which all the studied samples were hybridized against the
pool of equal amounts of RNA originating from all rats participating in the study. The cRNA
of common reference was labelled with Cy3 and the cRNA obtained from investigated tissues
were labelled with Cy5. Sixteen two-colour microarrays were performed, each representing
specific rat (n = 4 microarrays with stomach samples from C group; n = 4 microarrays with
middle intestine samples from C group; n = 4 microarrays with stomach samples from NOH
group and n = 4 microarrays with middle intestine samples from NOH group). The equal
amounts of cRNA samples (300ng) were hybridized on each slide. Since the microarrays were
dual-colour on each slide we hybridized one Cy3-labelled common reference sample and one
Cy5-labelled experimental rat sample. Once the microarrays were scanned after hybridization
and washing they were analysed in Agilent Feature Extraction (FE) Software version 10.7.3.1.
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FE. This software extracts the data and performs its background subtraction as well as per-
forms Lowess normalization of obtained intensities.
The probes intensities were than downloaded to PANTHER Version 13.0 software (Protein
ANalysis THrough Evolutionary Relationships) and Pathway Studio 11.4.0.8 software (Ari-
adne Genomics) in order to perform ontologic analyses, identify differentially regulated signal-
ling pathways and function of differentially regulated genes.
Verification of results by real-time PCR. The expression of two genes (MAP2K3 and
MAPK3) was verified using real-time PCR method. GAPDH was used as a reference gene.
Transcription of RNA to cDNA was done using High-Capacity cDNA Reverse Transcription
Kit (Applied Biosystems) and Real time PCR reaction was performed in triplicate using a Bril-
liant III Ultra-Fast SYBR Green QPCR Master Mix kit (Agilent Technologies, USA) on Strata-
gene Mx3005P Quantitative PCR instrument according to the manufacturer’s protocol.
Conditions of real time PCR reactions were according to the manufacturer’s protocol and
comprised the following steps: polymerase activation at 95˚C for 3 minutes; 40 cycles of ampli-
fication (95˚C for 10 seconds, 60˚C for 20 second). The primers were designed using Primer-
Blast software (NCBI database) and verified using Oligo Calc: Oligonucleotide Properties Cal-
culator (free software available online, provided by Northwestern University) to exclude
sequences showing self-complementarity. The sequences of primers were given in Table 1.
The results were calculated using 2- ΔΔCt method [9]. The expression changes were deter-
mined as relative expression of genes and normalized to reference gene GAPDH. The results
are presented as log2.
Sample preparation for histomorphometry, proliferation and apoptosis
rate
The preparation of the intestinal samples for the histomorphometry of the intestinal wall and
the assessment of the proliferation activity and apoptosis in the intestinal epithelium was per-
formed on paraffin embedded sections and described in detail by Słupecka et al. [10]. Briefly,
for intestinal histometry studies, slides were stained with hematoxylin and eosin. The villi
lengths, crypt depth, thickness of mucosal layer (from the tip of the villi to the bottom of the
crypt) were visualized using a light microscope (Axioskop 40, Zeiss, Germany) and analyzed
using Axio Vision 4.2 Release software (Zeiss, Germany).
The number of apoptotic epithelial cells was determined using a TUNEL assay (terminal
deoxynucleotidyl transferase-mediated dUTP nick end labeling). The procedure was per-
formed according to the manufacturer’s protocol for the assay (ApopTag, Merck Millipore,
Darmstadt, Germany USA). Slides were visualized using a microscope under 400x magnifica-
tion. The apoptotic index was estimated separately for crypt and villi area. The apoptotic index
was expressed as the number of apoptotic cells on all epithelial cells of villi and crypt respec-
tively. Proliferating crypt cells were immunostained for rabbit polyclonal anti- Ki67 antibodies
(Abcam, UK), 50 times diluted in 1% BSA-PBS and processed according to manufacturer’s
protocol for EnVision+system (DakoCytomation, Denmark), providing secondary antibodies
Table 1. Primers sequences used for real-time PCR.
Gene Forward primer (5’-3’) Revers primer (5’-3’) NCBI accession number
MAP2K3 CCATTCTGCGATTCCCTTAC GCAATGTCCGTCTTCTTAGT NM_001100674
MAPK3 GTCATAGGCATCCGAGACA CGCAGGTGGTGTTGATAAG NM_017347
GAPDH CTCTGCTCCTCCCTGTTCTA CAATGAAGGGGTCGTTGATG NM_017008.4
https://doi.org/10.1371/journal.pone.0205994.t001
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conjugated with HRP enzyme and the chromogen (diaminobenzidine) as the substrate for
HRP enzyme. The slides were counterstained with hematoxylin. The mitotic index was calcu-
lated as the number of Ki67 positive cells on all epithelial cells of the crypt cross-section. For
all abovementioned analysis a minimum of 15 well-oriented and intact villi and crypts were
randomly selected per slide by an investigator blinded to treatment allocation.
Immunofluorescence of obestatin
The immunofluorescence staining procedure was carried out according to the method
described in our previous publication [10]. After stomach samples were fixed in 10% neutral
formalin solution and rehydrated, they were incubated with the primary antibody against
obestatin in the block buffer (1% BSA-PBS), 200 times diluted then incubated with secondary
antibody conjugated with FITC (Abcam, UK). Both incubations were done at room tempera-
ture for 1h. After being rinsed 3 times, the slides were mounted, and visualized through a con-
focal microscope (model LSM 5 Pascal, Zeiss, Germany).
Western blotting
Tissue preparation, lysis, Western blotting and quantification were performed as a standard
procedure and were described previously [11]. In brief, the samples were separated by 15%
SDS-PAGE (Mini-Protean II Electrophoresis Cell, BioRad). 60 μg of proteins were transferred
to PVDF membranes (Merck Millipore, Darmstadt, Germany) and incubated with anti obesta-
tin antibody (Abcam, Great Britain) diluted to 1:200 at 4˚C overnight. Then, the membranes
were incubated with a horseradish peroxidase-conjugated antibody (Santa Cruz Biotechnol-
ogy, CA, USA) diluted to 1:500. Signals were detected by chemiluminescence using the West-
ern blotting luminol reagent and visualized using a ChemiDoc-It Imaging System (UVP, LLC.
Cambridge, UK). All bands visualized by chemiluminescence were quantified using Image J
analysis software (US National Institutes of Health, Bethesda, MD, USA). The blots were then
stripped and probed for anti-β-actin.
Brush border enzyme activity
Brush border enzyme activity was measured in the mucosa scrapings from the middle part of
the jejunum. The mucosa was scraped off with a microscope slide and deep-frozen in liquid
nitrogen (–80 ˚C). After thawing, the sample was homogenized in cold distilled water (1 g
intestinal mucosa/5 ml distilled water) and centrifuged for 5 min at 1000 g at 4 ˚C. The protein
content was then determined as described by Hartree [12], using BSA as the standard. The
activities of aminopeptidase A and N were assayed with N¨-glutamyl- p-nitroanilide and N¨-leu-
cyl-p-nitroanilide as substrates respectively [13] and that of dipeptidyl peptidase IV was
assayed with glycyl-N¨-prolyl-p-nitroanilide [14]. The resulting enzymatic units (IU) are
expressed as μmol p-nitroanilide released/min at 37 ˚C. Lactase, maltase and sucrase were
determined as described earlier [15] with minor modifications.
Markers of oxidative stress
The oxidative stress in the small intestinal tissue was investigated by the measurement of DNA
repair activity and gene expression of Cox-2.
DNA repair activity by nicking assay. The 1 cm length samples of middle jejunum were
homogenized with 4 volumes of 50 mM Tris—HCl, pH 7.5, buffer containing 1 mM EDTA
and protease inhibitor cocktail (Sigma Aldrich, Germany). Cells were disrupted by sonication
(three 15-s pulses with 30-s intervals). The cell debris was removed by centrifugation (7000 g,
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4 ˚C, 15 min), and the supernatant used as the source of DNA repair enzymes (alkyl-N-
purine-DNA (ANPG) and 8-oxoguanine DNA (OGG1) glycosylazes) was collected. Protein
concentration was determined by the Bradford method [16]. Supernatants were stored in ali-
quots at −80 ˚C for further analysis. Etheno adduct excision activity was measured by the nick-
ing assay using an oligodeoxynucleotide duplex containing a single 8oxoG (for OGG1 activity)
and ethenoA residue (for ANPG activity) according to Speina et al. [17] and Obtułowicz et al.
[18].
Gene expression of COX-2. The gene expression of Cox-2 was measured by Real Time
RT-PCR method [19–21]. Briefly, total RNA was extracted from rat tissue using the PureLink
RNA kit (Invitrogen, USA). RNA quantity and purity were determined using NanoDrop
microspectrophotometer ND-1000 (Wilmington, DE). One μg of total RNA was reverse-tran-
scribed to high capacity cDNA using a reverse transcription kit including mixture of random
primers (Applied Biosystems, Foster City, CA). Real time quantitative RT-PCR analysis was
carried out by SYBR Green I dye detection (Applied Biosystems, Foster City, CA) using the
real time detection system (Bio-Rad). Real-time PCR primers were designed with PrimerEx-
press software was as follows:
Cox-2 F, GATTGACAGCCCACCAACTT Exon 4, NM_017232
Cox-2 R, CGGGATGAACTCTCTCCTCA Exon 5
Primers were synthesized in DNA Sequencing and Oligonucleotide Synthesis Laboratory
IBB, PAS (Poland). Optimized conditions were as follows: 1 min at 48 ˚C, 7 min, and 30 s at
95 ˚C and 45 cycles of 20 s at 95 ˚C and 35 s at 62 ˚C in which an optical acquirement were per-
formed. Melt curves were performed upon completion of the cycles to ensure absence of non-
specific products. Quantification was performed by normalizing cycle threshold (Ct) values
with the Cox2 control gene 18s, and analysis was carried out with the 2−ΔΔCT method [9].
Obestatin and ghrelin radioimmunoassay
Rat plasma samples were assayed for obestatin and total ghrelin (acyl and des-acyl) concentra-
tion using commercially available radioimmunoassay (RIA) kits: Ghrelin (Rat, Mouse) RIA
Kit and Obestatin (Rat, Mouse) Ultra-Sensitive RIA Kit (Phoenix Pharmaceuticals, Inc., USA)
according to the manufacturer’s instructions. Spike and recovery of obestatin and total ghrelin
were measured in three different plasma samples. The assays were performed in one run. The
mean percent recovery for obestatin and ghrelin in plasma was 90% and 93%, respectively.
The intra-assay coefficient of variation (CV) for obestatin and ghrelin in plasma was 5.7 and
6.5%, respectively.
Statistics
The statistical analysis of microarrays was performed using Gene Spring 14 software (Agilent,
USA). The probe sets were filtering by flags to remove poor quality probes (absent flags). The
statistical significance of the differences was evaluated using a one-way ANOVA and Tukey’s
HSD Post-hoc test or Kruskal-Wallis test (p< 0.05). A multiple testing correction was per-
formed using Benjamini and Hochberg False Discovery Rate (FDR) < 0.05. Microarray data
were deposited at the Gene Expression Omnibus data repository under the number
GSE102217. The rest data obtained in the study were analyzed using an Unpaired t-test,
Mann-Whitney test, one-way ANOVA and Tukey’s post-hoc test or Kruskal-Wallis test
(p< 0.05) (Prism 6 for Mac OS X, Version 6.0h, GraphPad Software, Inc., USA).
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Results
Obestatin effect on body weight, adiposity and intestinal morphology
Enteral administration of obestatin in both studied doses had no effect neither on the body
weight of animals nor the BMI calculated in the day of euthanasia. Adiposity estimated either
by the weight of peritoneal fat pad did not differ between studied groups. No differences were
found in the weight and length of the intestine between studied groups (Table 2).
Obestatin effect on gene expression profile
Analysis started from identification of all differentially expressed (DE) genes between two
treatments in specific parts of gastrointestinal tract using Tukey’s HSD Post-hoc test. The
number of DE genes in stomach was 764 whereas in middle part of intestine was 992. In order
to identify the genes regulated by obestatin treatment the intersection of these two data sets
was created. It revealed 195 differentially expressed probes. Out of this group it was possible to
identify 131 transcripts representing specific genes (Fig 1A).
The analysis of Gene Ontology of this data set revealed significant regulation of genes
involved in biological functions (Fig 1C). The analysis of direct relations between differentially
regulated genes revealed that if we consider obestatin direct action on specific genes expression
the key regulated genes are MAP2K3 (coding mitogen- activated protein kinase kinase 3) and
MAPK3 (coding mitogen-activated protein kinase-3) which regulates expression of other dif-
ferentially regulated genes included tracriptional factor p53 with the crucial role in the cell
response to DNA damage (Fig 1B).
To validate the microarray data the expression of MAP2K3 and MAPK3 was analyzed using
real-time qPCR. The results showed significantly decreased expression of MAPK3 in the stom-
ach of rats treated with obestatin (OH) in comparison to control rats (C), (Fig 2A). Adminis-
tration of obestatin in a high dose (OH) had no statistically signicficant effect on MAP2K3 and
MAPK3 expression in the intestine (Fig 2B). However, when the stomach and intestine sam-
ples od rats treated with obestatin were analyzed together as one group OHALL (to show obes-
tatin effect in gastrointestinal track) we observed significant decrease in the expression of
MAP2K3 in comparison to tissues (stomach and intestine) not treated with the peptide (group
CALL), (Fig 2C).
The effect of obestatin administration on its blood plasma concentration
and peptide expression and localization in the stomach
In comparison with that in suckling rats administered saline solution, the obestatin concentra-
tion in blood plasma of suckling rats administered with obestatin was significantly increased
(p = 0.0061) in the group treated with the high dose (OH), (Fig 3A).
Table 2. Obestatin effect on body weight, adiposity and intestinal morphology in suckling rats.
Parameter / Group C OL OH P
Body weight (g) 36.9 ± 1.6 35.7 ± 1.0 36.0 ± 1.4 0.8286
BMI (kg/m2) 3.18 ± 0.07 3.24 ± 0.07 3.14 ± 0.08 0.6120
Peritoneal fat (g/ kg BW) 0.039 ± 0.006 0.039 ± 0.005 0.035 ± 0.005 0.8446
Small intestine weight (g/kg BW) 0.044 ± 0.001 0.046 ± 0.0009 0.046 ± 0.001 0.4922
Small intestine length (cm) 45.9 ± 1.1 47.4 ± 1.3 46.0 ± 1.2 0.6470
C—saline solution (twice a day); OL—intra stomach obestatin (125 nmol/kg BW, twice a day); OH—intra stomach obestatin (250 nmol/kg BW, twice a day); values are
given as means ± SEM.
https://doi.org/10.1371/journal.pone.0205994.t002
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Fig 1. Integrative analysis of microarray data identifying significantly changed genes. (A) Venn diagram of overlapping genes
which expression significantly changed in the stomach (blue) and intestine (yellow) after enteral administration of obestatin in
dose 250 ug/kg BW to suckling rats (group OH). (B) The analysis of direct relations between differentially regulated genes. (C)
Results of Gene Ontology analysis.
https://doi.org/10.1371/journal.pone.0205994.g001
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Fig 2. The relative expression of MAP2K3 and MAPK3mRNA measured with real-time PCR in extracts from rats
gastrointestinal tract. (A) Genes expression in the stomach of suckling rats administered with saline solution (group
C) and after enteral administration of obestatin in dose 250 ug/kg BW (group OH); � p = 0.0314. (B) Genes expression
in the intestine of suckling rats administered with saline solution (group C) and after enteral administration of
obestatin in dose 250 ug/kg BW (group OH). (C) Genes expression in the gastrointestinal tissues (stomach+ intestine)
Obestatin effects on rats’ small intestine
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Western blot and immunohistochemical analyzes detected that enteral obestatin adminis-
tration to suckling rats influences on its peptide expression in the stomach (Fig 3B and 3C).
Administration of the lower dose of obestatin (OL) significantly increased both the peptide
expression in the stomach (Fig 3B) and the percentage of cells containing visible antigen in
comparison to control animals (C), (p = 0.0012 and p = 0.0016, respectively) (Fig 3D). High
dose of obestatin (OH) gave the opposite effect, a significant decrease in comparison to C
group. Immunohitochemistry revealed obestatin localization in the oxyntic gland of gastric
mucosa predominantly in the base and neck area (Fig 3C).
Obestatin effect on intestinal epithelium renewal
Enteral administration of both studied doses of obestatin resulted in significant decrease in the
thickness of mucosa layer and length of the villi as compare to C group (p = 0.0001). Moreover,
in the OH group also the depth of the intestinal crypts were significantly decreased
(p = 0.0003) as compare to control animals (C), (Figs 4A and 5A). We observed, increase in
the apoptosis rate (p = 0.0061) on the top of the villi in the group receiving lower dose of obes-
tatin (OL) as compare to control group C, (Figs 4B and 5B). However, the apoptosis in the
crypts were unaffected (Figs 4B and 5C). Administration of obestatin in higher dose decreased
(p = 0.0228) proliferation activity of the crypt stem cells (Figs 4C and 5D).
Obestatin effect on the activity of brush border enzymes
Administration of obestatin in a high dose (OH) had no statistically signicficant effect on the
activity of examined brush border enzymes (lactase, aminopeptidase A and N, sucrose, malt-
ase, dipeptidyl peptidase 4, sucrase) comparing to suckling animal treated only with saline
solution (C). To distinguish, lower dose of obestatin administrated enterally changes the pro-
file of enzymes activity observed in suckling rats. Compare with control animals (C) treating
rats with 125 ug/kg BW for seven days (OL) resulted in elevation in lactase activity
(p = 0.0265) and reduction in aminopeptidase N (p = 0.0339) and maltase (p = 0.0220)
(Table 3).
DNA repair activity assay
The repair activity assay revealed significant increase in 8oxo-G in both groups supplemented
with obestatin (p< 0.001) in comparision to C group. Moreover, the observed increase was
dose dependent. The rate of eteno-A in the jejunum was significantly elevated (p = 0.0021) in
rats administered with high dose of obestatin as compare to other studied groups (Fig 6).
Obestatin effect on Cox-2 expression
The expression of COX-2 mRNA was significantly increased (p< 0.0001) in the group admin-
istered with the high dose of obestatin (OH) as compared to group supplemented with lower
dose of obestatin (OL) and control animals (C), (Fig 7).
Discussion
Previous studies of our team indicated that obestatin when administered enterally in pharma-
cological doses 125 nmol/kg BW or 250 nmol/kg BW significantly influences small intestinal
of suckling rats administered with saline solution (group CALL) and animals treated with obestatin in dose 250 ug/kg
BW (group OHALL);
� p = 0.312. Values are given as means ± SEM.
https://doi.org/10.1371/journal.pone.0205994.g002
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Fig 3. Obestatin effect on its concentration in plasma (A), peptide expression (B, D) and localization (C) in suckling rats. A)
Radioimmunological assessment of obestatin concentration (pg/ml) in blood plasma. (B) Western blot analysis of obestatin
expression in the middle jejunum segments in suckling rats. Results are presented as the optical density of the obestatin b-actin ratio
in the study groups, performed in 6 replications. (C) Obestatin expression on confocal images in representative cross-sections from
the stomach fundus of suckling rats. Obestatin cells are marked by green fluorescence. Nuclei were stained with 7-AAD (red
Obestatin effects on rats’ small intestine
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contractility of suckling rat neonates by decreasing the amplitude of contraction. The observed
obestatin effect was independent both from Cajal cells and expression of M2 muscarinic recep-
tors [4]. The above mentioned study together with previous studies of our team showing ghre-
lin impact on remodeling of the small intestinal mucosa in neonatal rats [10] were a premise to
studies on obestatin effect on the process of intestinal development in suckling rats. As the pro-
cess of development consists of both growth and maturation we presented comprehensive
study on both structural growth and changes in the activity of brush border enzymes, which
provide functional gut maturation. In the present study we shown that enteral administration
of obestatin when given in dose 250 nmol/kg b.wt twice a day to suckling rats significantly
increase the level of obestatin in the circulation but markedly inhibits endogenous synthesis of
obestatin in the stomach what was confirmed both by immunocytochemical analysis showing
the percentage of cells containing visible antigen irrespectively of its amount, and by Western
fluorescence), (400x). (D) Mean number of obestatin cells in the oxyntic mucosa of stomach fundus per field of view (400x), n = 6.
C—animals administered with saline solution (twice a day); OL—intra stomach obestatin (125 nmol/kg BW, twice a day); OH—
intra stomach obestatin (250 nmol/kg BW, twice a day); values are given as means ± SEM; different superscript letters indicate
statistical differences between the groups; p� 0.05.
https://doi.org/10.1371/journal.pone.0205994.g003
Fig 4. Obestatin effect on intestinal epithelium renewal in suckling rats. (A) The effect of enteral obestatin administration on histometry
of small intestinal in suckling rats. (B) Apoptotic index (%) of crypt and villous small intestinal epithelial cells after enteral obestatin
administration, n = 6 (C) Mitotic index (%) of crypt small intestinal epithelial cells after enteral administration of obestatin, n = 6. C—
animals administered with saline solution (twice a day); OL—intra stomach obestatin (125 nmol/kg BW, twice a day); OH—intra stomach
obestatin (250 nmol/kg BW, twice a day); values are given as means ± SEM; different superscript letters indicate statistical differences
between the groups; p� 0.5.
https://doi.org/10.1371/journal.pone.0205994.g004
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Fig 5. Microscopic images in representative cross-sections from the small intestine mucosa of suckling rats. (A) Histometry
of small intestinal wall in suckling rats (light microscope, 100x). (B) Apoptosis of villous small intestinal epithelial cells (confocal
microscope, 400x). (C) Apoptosis of crypt small intestinal epithelial cells (confocal microscope, 400x). (D) Mitosis of crypt small
intestinal epithelial cells (light microscope, 400x). C—animals administered with saline solution (twice a day); OL—intra stomach
obestatin (125 nmol/kg BW, twice a day); OH—intra stomach obestatin (250 nmol/kg BW, twice a day).
https://doi.org/10.1371/journal.pone.0205994.g005
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blotting that shows total amount of antigen in tissue homogenates. The administration of
lower dose of obestatin (125 nmol/ kg BW) had no significant effect on the obestatin concen-
tration in the blood but significanty increased the endogenous expression of the peptide what
was confirmed by Western blotting.
In both doses, enteral administration of obestatin effects on the intestinal development. In
case of treatment with lower dose of obestatin we observed increase in the lactase activity
together with the significant decrease in the activity of maltase what may suggest the retard-
ment in the intestinal maturation. In comparison to control rat pups suckling their mothers
we observed that administration of lower dose of obestatin decreases villi length due to
increased apoptosis of small intestinal epithelial cells. Unlike lower dose, obestatin adminis-
tered in dose 250 nmol/kg BW had no effect on the activity of brush border enzymes. However
Table 3. The activity of brush border enzymes after enteral administration of obestatin to suckling rats.
Parameter / Group C OL OH P
Protein (mg/ml) 500 ± 8a 465 ± 7b 456 ± 10b 0.0022
Aminopeptidase A 2.68 ± 0.10 2.35 ± 0.17 2.89 ± 0.24 0.3820
Aminopeptidase N 1.65 ± 0.12a 1.21 ± 0.13b 1.65 ± 0.15ab 0.0339
Dipeptidase IV 0.98 ± 0.05 0.92 ± 0.07 0.95 ± 0.08 0.7827
Lactase 1.39 ± 0.20a 2.34 ± 0.29b 1.81 ± 0.11ab 0.0294
Maltase 0.12 ± 0.01a 0.07 ± 0.01b 0.12 ± 0.009a 0.0220
Sucrase 0.62 ± 0.03ab 0.92 ± 0.10a 0.52 ± 0.06b 0.0265
C—saline solution (twice a day); OL—intra stomach obestatin (125 nmol/kg BW, twice a day); OH—intra stomach obestatin (250 nmol/kg BW, twice a day); values are
given as means ± SEM; different superscript letters indicate statistical differences between the groups; p� 0.05.
https://doi.org/10.1371/journal.pone.0205994.t003
Fig 6. Obestatin effect on the excision of ethenoadducts in the small intestine of suckling rats. (A) ethenoadducts
excision by increasing amounts of extracts from analyzed samples (green numbers) and control samples (red
numbers). The amount of cleaved oligodeoxynucleotide was estimated by PhosphorImaging, and repair capacity was
calculated from the linear part of the curve. The activity of 8oxo-G in the small intestinal segments. (B) the activity of
eteno-A in the small intestine samples. C—animals administered with saline solution (twice a day); OL—intra stomach
obestatin (125 nmol/kg BW, twice a day); OH—intra stomach obestatin (250 nmol/kg BW, twice a day); values are
given as means ± SEM; different superscript letters indicate statistical differences between the groups; p� 0.05.
https://doi.org/10.1371/journal.pone.0205994.g006
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we observed changes in the structure of intestinal epithelium (decreased length of the villi and
crypt depth) resulting from significant decrease in stem cell proliferation. These results are sur-
prising as previous studies on colonic mucosa under colitis, human retinal epithelial cells [22]
and porcine preadipocites [23] revealed that obestatin enhances proliferation and inhibits apo-
ptosis. The reason of these differences is hard to explain however two aspects should be under-
line. First, in our study we used higher doses of obestatin than abovementioned studies.
Moreover, our previous studies have shown that obestatin effect is strongly dependent on the
age of animals and in consequence influenced by the number of myenteric neurons, function-
ally active receptors and their sensitivity, as well as the release of neurotransmitters, thus in
turn affecting obestatin induced contractility.
As the higher dose of obestatin administered enterally managed to inhibit significantly the
expression of endogenous obestatin in the stomach we performed micrroarays to check the
consequences of this silencing. We showed that higher dose of obestatin effects on the profile
of 131 genes. These genes among others are involved in neutrophil recruitment, priming and
activation. The anti-inflammatory effect of obestatin regulated by the neutrophils were previ-
ously reported. However, in our study we have also observed the increase in the rate of 8-oxo
G and eteno A together with the increased COX-2 expression. Etheno-DNA adducts are muta-
genic and carcinogenic and they are formed by the reaction of lipidperoxidation (LPO) prod-
ucts as well as being induced by external environmental factors stimulated by a specific diet.
These factors induce the formation of alkylation of damaged bases in etheno-DNA, which
includes 1,N6-etheno-20-deoxyadenosine (εdA), 3,N4-etheno-20-deoxycytidine (εdC), 1,N2-
etheno-20-deoxyguanosine (1,N2-εdG) and the oxidation of bases whose marker in the cell is
8-oxo-7,8-dihydroguanine, (8oxoG), [24]. These lesions are recognized and repaired by
enzymes from the repair glycosylation group: ANPG for (εdA), and OGG1 for (8oxoG), in the
base excision repair (BER) process [24,25]. One of the reasons the LPO products are generated
is inflammation driven by oxidative stress. Oxidative stress is a complication that occurs when
the generation of reactive oxygen species (ROS) exceeds antioxidant enzyme activity [26].
Moreover, we have observed increased expression of Cox-2 which posses pro-inflammatory
Fig 7. The level of COX-2 mRNA in relation to 18 S rRNA in extracts from rats small intestine. C—animals
administered with saline solution (twice a day); OL—intra stomach obestatin (125 nmol/kg BW, twice a day); OH—
intra stomach obestatin (250 nmol/kg BW, twice a day); values are given as means ± SEM; different superscript letters
indicate statistical differences between the groups; p� 0.05.
https://doi.org/10.1371/journal.pone.0205994.g007
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activities and is up-regulated by hormones, growth factors but also during inflammation. Cox-
2 is synthetized by active neutrophils what leads to the synthesis of prostaglandin (PE) E2, an
important mediator of many biological functions, such as regulation of immune responses,
blood pressure, gastrointestinal integrity, and fertility [27]. All together suggests that obestatin
when given enterally in dose 250 nmol/kg BW activates signaling pathway connected with
inflammation and the integrity of the small intestinal mucosa. Opposite effect of obestatin was
shown in several studies claiming anti-inflammatory [28], anti-oxidant and anti-apoptotic
properties [29]. The observed opposite effects of obestatin may be connected with aspects
which were mentioned above like the age related changes in the density of obestatin receptors
or/and the route of peptide administration. It should be highlighted that studies showing anti-
inflammatory, anti-oxidant and anti-apoptotic effects of obestatin investigated obestatin role
in disease not in the physiological state. Pomukcu et al [28] shown that obestatin has anti-
inflammatory effect in rat colitis but the effectiveness of this effect was dependent on its form
(acute vs. chronic). That suggests that state of immune system determine the response of obes-
tatin. It should be also mentioned that gene profile revealed that key regulated genes after obes-
tatin administration in higher dose are mitogen-activated protein kinases: MAPK3 and
MAP2K3 which regulate pathways mediating inflammation, cell survival, cell death, prolifera-
tion and differentiation. It should be mentioned that obestatin intracellular mechanism of
action via MAP kinase and p53 was previously reported in the studies on porcine ovarian
granulosa cells [30]. Our observations provide evidence that enteral obestatin besides influenc-
ing intestinal contractility effects small epithelial cell remodeling in suckling rats. The profile
of changes observed in the small intestine after enteral treatment with obestatin suggests that
this effect in case of long lasting administration will not be supportive for growth and develop-
ment but could be even harmful. The studies showing lower concentration of obestatin in the
maternal milk for preterm neonates as compare to milk of neonate born in time may support
this observation. Maternal milk, the gold standard providing the best growth and development
has limited amounts of obestatin for preterms susceptible for inflammation. The further stud-
ies are needed to understand obestatin role in the early postnatal development.
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